This multicenter study of patients after liver resection for hilar cholangiocarcinoma evaluates whether the number of positive lymph nodes or the lymph node ratio was most accurate for staging.
This study assesses the hierarchy and interaction of factors associated with the risk for liver decompensation in patients undergoing liver resection for hepatocellular carcinoma.
This case series used a review of medical records to investigate the effect of costs of an index hospital admission on subsequent readmission rates among patients undergoing colorectal, pancreatic, or hepatic resection.
The study evaluates trends in transfusion rates for major abdominal oncologic resections to assess changes in recent clinical practice (given the accumulating evidence of the deleterious effects of blood transfusion).
This cohort study uses data on patients who underwent liver resection for hepatitis B virus–related hepatocellular carcinoma to develop a nomogram for preoperative estimation of microvascular invasion.
This study of patients undergoing hepatopancreaticobiliary surgery reports significant variability in hospital costs associated with patient and hospital characteristics.
This Viewpoint discusses the benefits of the associating liver partition and portal vein ligation for staged hepatectomy approach for treating liver tumors.
This Viewpoint discusses the associating liver partition and portal vein ligation (ALPPS) procedure vs portal vein embolization for safe and effective generation of future liver remnant hypertrophy for hepatectomy.
This single-center study investigates the prognostic impact of specific KRAS mutations on the survival of patients undergoing liver resection for colorectal liver metastases.
Franken et al compare short-term (30-day) outcomes between laparoscopic and open partial hepatectomies. An Invited Commentary by Biehl follows.
Mavros et al conduct a systematic review and meta-analysis to evaluate the available evidence regarding treatment and prognosis in patients with intrahepatic cholangiocarcinoma.
Hall and colleagues identified live liver donors in the Nationwide Inpatient Sample to determine generalizable estimates for postoperative complications following donor hepatectomy and to explore patient- and hospital-level factors associated with complications.
In a retrospective analysis, Fischer et al determine whether the administration of chemotherapy mitigates tumor growth after portal vein embolization that is performed before major hepatectomy for metastatic colorectal cancer.